Prognomiq Inc

Prognomiq Inc company information, Employees & Contact Information

Explore related pages

Related company profiles:

PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment. Powerful, Untapped Disease Insights Built on a Proteomics Foundation: Until now, there have been major technical and economic barriers to broad-scale proteomics analyses, leaving this rich resource of molecular information largely untapped for clinical purposes. These barriers have now been largely addressed through next generation tools that can elucidate complex proteomics at scale. Complementary Molecular Information: Genomic data has made clear contributions to researchers’ abilities to understand and more precisely treat disease, but it is has shown limited impact on early-stage disease detection. Proteomics provides direct information on the biological state of a cell, including disease at its earliest state, but proteomics data has been technically difficult to generate – until now. By complementing the new sources of proteomics data with genomics and other data, such as metabolomics, we now have the tools to generate powerful multi-omics data that will be the key to unlock the detection and treatment of disease at its earliest stages, when these diseases are most likely to be cured. Unlocking Disease Detection and Treatment with Multi-omics Data: We designed our proprietary multi-omics platform around the most robust approaches to generating proteomic, genomic and metabolomics data at scale, including the use of the Proteograph technology platform from the life science tools company Seer (NASDAQ: SEER) whom PrognomiQ spun out of in 2020.

Company Details

Employees
59
Founded
-
Address
1900 Alameda De Las Pulgas,
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Forum.
HQ
San Mateo, California
Looking for a particular Prognomiq Inc employee's phone or email?

Prognomiq Inc Questions

News

PrognomiQ Appoints Joel Kaufman as Chief Financial Officer - GlobeNewswire

PrognomiQ Appoints Joel Kaufman as Chief Financial Officer GlobeNewswire

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform - Yahoo Finance

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform Yahoo Finance

PrognomiQ Announces $46 Million Financing to Advance Development of its Multi-omics Product Pipeline for Early Detection and Treatment of Cancer - PR Newswire

PrognomiQ Announces $46 Million Financing to Advance Development of its Multi-omics Product Pipeline for Early Detection and Treatment of Cancer PR Newswire

PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer - HIT Consultant

PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer HIT Consultant

Wilson Sonsini Advises PrognomiQ on Patent Matters Related to $34 Million Series D - Wilson Sonsini

Wilson Sonsini Advises PrognomiQ on Patent Matters Related to $34 Million Series D Wilson Sonsini

timsTOF HT Improves Protein Identification and Quantitative Reproducibility for Deep Unbiased Plasma Protein Biomarker Discovery - ACS Publications

timsTOF HT Improves Protein Identification and Quantitative Reproducibility for Deep Unbiased Plasma Protein Biomarker Discovery ACS Publications

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancer - medRxiv

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancer medRxiv

PrognomiQ's Latest Research Demonstrates the Potential of its Multi-omics Liquid Biopsy Platform in Early-Stage Detection of Lung Cancer - BioSpace

PrognomiQ's Latest Research Demonstrates the Potential of its Multi-omics Liquid Biopsy Platform in Early-Stage Detection of Lung Cancer BioSpace

Maccabi's KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection - PR Newswire

Maccabi's KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection PR Newswire

PrognomiQ Strengthens its Scientific and Clinical Leadership with the Appointment of Brian Koh, M.D. as Chief Medical Officer - PR Newswire

PrognomiQ Strengthens its Scientific and Clinical Leadership with the Appointment of Brian Koh, M.D. as Chief Medical Officer PR Newswire

Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing - GlobeNewswire

Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing GlobeNewswire

Top Prognomiq Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant